Primary Menu

Janine Davis

Middays Weekdays 10:00AM-3:00PM

More than 34 million Americans have diabetes. And approximately 90-95% of them have type 2 diabetes. The Food and Drug Administration has sounded the alarm and recalled the diabetes drug metformin hydrcholoride, saying it has high levels of a cancer-causing agent.

Marksans Pharma Limited manufactures the drug. The recalled drug  is the “extended-release tablets” under the brand name Time-Cap Labs, Inc. The recall applies to tablets between 500 mg and 750 mg. The drug lowers blood glucose levels in type 2 diabetes patients.

In tests, Marksana Pharma found the drug contained an unacceptably high level of Nitrosodimethylamine, which is considered a probable human carcinogen. The FDA is still investigating where NDMA comes from and how it ends up in metformin products.

The recall applies to the following products, which can be identified by their National Drug Code numbers listed below. Each tablet has either 101 or 102 on one side and is plain on the other. Patients should contact their physician with any questions.
Metformin Hydrochloride Extended-Release Tablets, USP 500mg:
90 counts: 49483-623-09
100 counts: 49483-623-01
500 counts: 49483-623-50
1000 counts: 49483-623-10
Metformin Hydrochloride Extended-Release Tablets, USP 750mg:
100 counts: 49483-624-01